CureVac N.V. (CVAC) Investment Research Dashboard
About CureVac N.V. (CVAC) stock analysis
Get live CVAC stock price $4.66, comprehensive CureVac N.V. stock analysis, charts, news, sentiment, sector analysis, and expert forecast. Real-time CVAC stock data and investment insights.
Loading chart data...
CureVac N.V. (CVAC) Overview
CureVac N.V. (CVAC) is a publicly traded company in the Healthcare sector , specifically within the Biotechnology industry . As of the latest trading session, CVAC trades at $4.66 with a market capitalization of 1.05B . Over the past 52 weeks, CVAC has traded between $2.48 and $5.72 , with the current price positioned at approximately 67% of this range . The stock currently trades at a price-to...
Key Takeaways
- Operates in the Healthcare sector (Biotechnology)
- Market cap: 1.05B
- Current price: $4.66
- 52-week range: $2.48 - $5.72
- P/E ratio: 6.96
Investment Score
A systematic tri-factor framework (valuation, quality, momentum) using trailing twelve-month fundamentals and current price momentum—aligned with the full investment score dashboard.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
CureVac N.V. is a biopharmaceutical company currently in the clinical stage, specializing in creating innovative medical treatments leveraging messenger ribonucleic acid (mRNA) technology. Its portfolio encompasses various mRNA-based prophylactic vac...
Company Information
- CEO
- Alexander Zehnder
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 825
Contact Information
- Website
- https://www.curevac.com
- Address
- Friedrich-Miescher-Strasse 15
- Country
- DE
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Valuation metrics suggest potential value opportunity (P/E: 7.0)
✓ Higher growth potential with elevated volatility (Beta: 1.84)
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for CureVac N.V. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for CureVac N.V.
- ⚠Investors should consider how CureVac N.V. fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
1.05B
P/E Ratio (TTM)
6.96
Beta
1.84
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare CVAC with peer companies:
- Price
- $18.90+2.66% (1D)
- Market cap
- 2.10B
- Price
- $55.08+4.02% (1D)
- Market cap
- 3.93B
- Price
- $9.15+1.32% (1D)
- Market cap
- 1.23B
- Price
- $83.77+2.72% (1D)
- Market cap
- 1.23B
- Price
- $72.46+2.14% (1D)
- Market cap
- 1.42B
- Price
- $7.73+3.42% (1D)
- Market cap
- 1.27B
- Price
- $12.28+1.32% (1D)
- Market cap
- 1.27B
- Price
- $19.00+3.04% (1D)
- Market cap
- 3.32B
- Price
- $21.20+1.85% (1D)
- Market cap
- 1.88B
- Price
- $47.98+0.00% (1D)
- Market cap
- 1.23B
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.
Healthcare (1D)
81/100 ⭐⭐⭐⭐⭐
- Overall
- +0.3%
- NYSE
- -0.1%
- NASDAQ
- +0.8%
| Sector | 1D | 1W | 1M | P/E | Score |
|---|---|---|---|---|---|
| Financial Services | +0.1% | +1.3% | +2.0% | 19.3 | 82/100⭐⭐⭐⭐⭐ |
| Healthcare | +0.3% | +2.8% | +1.6% | 23.6 | 81/100⭐⭐⭐⭐⭐ |
| Communication Services | +0.8% | -2.0% | +2.3% | 22.2 | 70/100⭐⭐⭐⭐⭐ |
| Consumer Defensive | +1.1% | +1.3% | +0.1% | 29.0 | 66/100⭐⭐⭐⭐ |
| Energy | +0.9% | +0.7% | -1.3% | 19.7 | 64/100⭐⭐⭐⭐ |
| Real Estate | -0.4% | +2.3% | -1.5% | 29.6 | 54/100⭐⭐⭐ |
| Basic Materials | -0.4% | +0.7% | -1.5% | 25.0 | 46/100⭐⭐⭐ |
| Utilities | -1.0% | +2.2% | -2.2% | 25.6 | 44/100⭐⭐⭐ |
| Consumer Cyclical | +0.5% | -1.4% | -3.8% | 42.9 | 18/100⭐ |
| Industrials | -0.8% | -0.4% | -9.2% | 30.6 | 13/100⭐ |
| Technology | -1.9% | -1.1% | -5.6% | 42.0 | 12/100⭐ |
Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-07-27.